ArticleBMC nutrition2025
Type 2 diabetes mellitus with chronic kidney disease benefits from long-term restriction of dietary protein intake: a 10-year retrospective cohort study.
Article in BMC nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The hallmarks of protein and amino acid restriction in aging and longevity.Cell press blue · 2026Article
- Association Between Time-Averaged Serum Uric Acid and Renal Outcomes in Patients with Type 2 Diabetes Mellitus with Chronic Kidney Disease: A Multicenter Retrospective Cohort Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Article
- Clinical efficacy, safety, and predictors of treatment response to SGLT2 versus DPP-4 inhibitors in type 2 diabetes: a retrospective comparative study.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveThis study aimed to investigate the relationship between long-term dietary protein intake (DPI) restriction and clinical outcomes in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD).
methodsWe conducted a retrospective study in both T2DM with CKD cohort from eight centers, with a follow-up period from January 2014 to September 2023 and the National Health and Nutrition Examination Survey (NHANES) dataset. DPI was evaluated based on the serum urea creatinine ratio (sUCR). The primary outcomes included initiation of dialysis, progression to end-stage renal disease, renal transplant, serum creatinine doubling, cardiovascular and cerebrovascular diseases.
resultsIn the T2DM with CKD cohort, 820 patients were selected from a total of 856 and categorized into three groups, propensity score matching at a 1:1:1 ratio, according to their DPI
conclusionOur data provide the strong evidence that T2DM patients with CKD benefits from long-term restriction of DPI CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.